Homology Medicines gets new chief medical officer

Mar. 09, 2023 8:37 AM ETHomology Medicines, Inc. (FIXX)By: Manshi Mamtora, CFA
  • Genetic medicines company, Homology Medicines (NASDAQ:FIXX) announced that Julie Jordan, M.D., has been promoted to Chief Medical Officer.
  • Previously, Dr. Jordan held the role of senior VP, Head of Clinical Development and Operations, at Homology, and she has been instrumental in advancing Homology’s gene editing and gene therapy clinical programs.
  • Prior to Homology, Dr. Jordan was responsible for clinical and scientific development activities at Cerevel Therapeutics, including global trials for schizophrenia, focal epilepsy and anxiety disorder. 

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.